A leading global company specializing in distribution of biosmilars
A biosimilar is a biologic product developed and proven to be biologically identical to a previously approved biologic known as the reference product using the same active substances. Known for its quality and affordability, biosimilars have become innovative medicines for patients with different diseases across the world
- The first mAb biosimilar
in the world
- Over the past few years, Celltrion Healthcare has been offering biosimilars for the treatment of autoimmune diseases in the global market and accumulating its marketing and distribution knowhow. Biosimilars have enabled patients from all over the world to benefit from a wide range of healthcare services and for each country to reduce the fianancial burden associated with health care services.
- Introducing new treatment options by changing the delivery type
- A product with a new delivery type will improve patient convenience and offer new treatment options to clinicians. Celltrion Healthcare will play a crucial role in making this happen, based on the prescription data accumulated over many years and the company's success in the global distribution of its products.